PACIRA BIOSCIENCES INC. - COMMON STOCK

Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $42.6 Million for February 2022

15 мар 2022 07:00:03 Источник Nasdaq GlobeNewswire

Pacira BioSciences to Participate in Fireside Chat at the Barclays Global Healthcare Conference

09 мар 2022 07:00:01 Источник Nasdaq GlobeNewswire

Pacira BioSciences Reports Full-Year and Fourth Quarter 2021 Financial Results

24 фев 2022 07:00:02 Источник Nasdaq GlobeNewswire

Pacira to Report 2021 Financial Results on Thursday February 24, 2022

16 фев 2022 07:00:02 Источник Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $37.3 Million for January 2022

15 фев 2022 07:00:02 Источник Nasdaq GlobeNewswire

Pacira Reports Preliminary Unaudited Total Revenue for 2021 of $540.7 Million to $541.7 Million

06 янв 2022 07:00:02 Источник Nasdaq GlobeNewswire

Pacira BioSciences to Present at the 40th Annual J.P. Morgan Healthcare Conference

03 янв 2022 07:00:01 Источник Nasdaq GlobeNewswire

Pacira BioSciences Announces Closing of $375 Million Five-Year Term Loan B

09 дек 2021 07:00:02 Источник Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL® and iovera° of $48.0 Million for November 2021

07 дек 2021 07:00:02 Источник Nasdaq GlobeNewswire

Pacira BioSciences to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

23 ноя 2021 07:00:00 Источник Nasdaq GlobeNewswire

Pacira BioSciences Completes Acquisition of Flexion Therapeutics and Strengthens Leadership Position in Non-Opioid Pain Management

19 ноя 2021 07:40:10 Источник Nasdaq GlobeNewswire

Pacira BioSciences to Present at the Jefferies London Healthcare Conference

10 ноя 2021 07:00:02 Источник Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $44.3 Million for October 2021

09 ноя 2021 07:00:02 Источник Nasdaq GlobeNewswire

Pacira Files Lawsuit Against eVenus for Patent Infringement

08 ноя 2021 15:30:14 Источник Nasdaq GlobeNewswire

Pacira BioSciences Reports Third Quarter 2021 Financial Results

03 ноя 2021 07:00:03 Источник Nasdaq GlobeNewswire

Pacira Receives Notice of Allowance for New Patent Covering EXPAREL Composition

02 ноя 2021 06:30:00 Источник Nasdaq GlobeNewswire

Pacira to Report Third Quarter 2021 Financial Results on Wednesday November 3, 2021

27 окт 2021 06:30:00 Источник Nasdaq GlobeNewswire

Pacira BioSciences to Acquire Flexion Therapeutics Further Expanding Leadership Position in Non-Opioid Pain Management

11 окт 2021 06:00:00 Источник Nasdaq GlobeNewswire

Pacira BioSciences to Host Investor Day on October 15th, 2021 in Tampa, FL

08 окт 2021 07:00:00 Источник Nasdaq GlobeNewswire

Pacira BioSciences Notified of Abbreviated New Drug Application Filing for EXPAREL®

04 окт 2021 06:30:00 Источник Nasdaq GlobeNewswire